Research graph
References from The TOP ‐ GERD Trial: Comparative Efficacy of Tegoprazan Versus Pantoprazole in the Treatment of Erosive Oesophagitis in a Non‐Asian Population. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s2468‐1253(19)30408‐x
10.1016/s2468‐1253(19)30408‐x · External reference
10.14309/ajg.0000000000001538
10.14309/ajg.0000000000001538 · External reference
10.1111/nmo.14075
10.1111/nmo.14075 · External reference
10.1016/j.cgh.2022.01.025
10.1016/j.cgh.2022.01.025 · External reference
10.1007/s11894‐024‐00939‐3
10.1007/s11894‐024‐00939‐3 · External reference
10.1111/apt.16295
10.1111/apt.16295 · External reference
10.1124/jpet.118.254904
10.1124/jpet.118.254904 · External reference
10.1111/apt.15438
10.1111/apt.15438 · External reference
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Oral Doses of CJ‐12420 (Tegoprazan), a Novel Potassium‐Competitive Acid Blocker (P‐CAB) in Healthy Male Subjects
10.1016/j.clinthera.2017.05.306 · 2017 · External reference
10.1111/apt.15185
10.1111/apt.15185 · External reference
10.1111/apt.17255
10.1111/apt.17255 · External reference
10.1111/nmo.14969
10.1111/nmo.14969 · External reference
10.1097/cm9.0000000000003276
10.1097/cm9.0000000000003276 · External reference
10.3389/fphys.2025.1675457
10.3389/fphys.2025.1675457 · External reference
10.1136/gutjnl‐2016‐313589
10.1136/gutjnl‐2016‐313589 · External reference
10.1002/cpt.2015
10.1002/cpt.2015 · External reference
10.1136/gut.45.2.172
10.1136/gut.45.2.172 · External reference
10.1136/gutjnl‐2023‐330616
10.1136/gutjnl‐2023‐330616 · External reference
10.1097/mcg.0000000000002352
10.1097/mcg.0000000000002352 · External reference
10.1080/003655298750026697
10.1080/003655298750026697 · External reference
10.1111/j.1442‐2050.2007.00658.x
10.1111/j.1442‐2050.2007.00658.x · External reference
10.7759/cureus.83302
10.7759/cureus.83302 · External reference
